-
1دورية أكاديمية
المؤلفون: Kristensen, Soren L., Preiss, David, Jhund, Pardeep S., Squire, Iain, Cardoso, Jose Silva, Merkely, Bela, Martinez, Felipe, Starling, Randall C., Desai, Akshay S., Lefkowitz, Martin P., Rizkala, Adel R., Rouleau, Jean L., Shi, Victor C., Solomon, Scott D., Swedberg, Karl, Zile, Michael R., McMurray, John J. V., Packer, Milton
المساهمون: Neyses, Ludwig
المصدر: Circulation: Heart Failure, 9 (1) (2016)
مصطلحات موضوعية: Aged, Aminobutyrates/adverse effects/therapeutic use, Angiotensin Receptor Antagonists/adverse effects/therapeutic use, Angiotensin-Converting Enzyme Inhibitors/adverse effects/therapeutic use, Biomarkers/blood, Blood Glucose/metabolism, Comorbidity, Diabetes Mellitus/blood/diagnosis/epidemiology/mortality, Disease-Free Survival, Drug Combinations, Enalapril/adverse effects/therapeutic use, Female, Heart Failure/blood/diagnosis/drug therapy/mortality/physiopathology, Hemoglobin A, Glycosylated/metabolism, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Prediabetic State/blood/diagnosis/epidemiology/mortality, Prevalence, Proportional Hazards Models, Prospective Studies, Risk Assessment, Risk Factors, Single-Blind Method, Stroke Volume, Tetrazoles/adverse effects/therapeutic use, Time Factors, Treatment Outcome
العلاقة: urn:issn:1941-3297; https://orbilu.uni.lu/handle/10993/29587Test; info:hdl:10993/29587; https://orbilu.uni.lu/bitstream/10993/29587/1/hhf-9-e002560.pdfTest; scopus-id:2-s2.0-84955319328; info:pmid:26754626; wos:000368624200001
الإتاحة: https://doi.org/10.1161/CIRCHEARTFAILURE.115.002560Test
https://orbilu.uni.lu/handle/10993/29587Test
https://orbilu.uni.lu/bitstream/10993/29587/1/hhf-9-e002560.pdfTest -
2دورية أكاديمية
المؤلفون: McMurray, John J. V., Packer, Milton, Desai, Akshay S., Gong, Jianjian, Lefkowitz, Martin P., Rizkala, Adel R., Rouleau, Jean L., Shi, Victor C., Solomon, Scott D., Swedberg, Karl, Zile, Michael R.
المساهمون: Neyses, Ludwig
المصدر: The New England journal of medicine, 371 (11), 993-1004 (2014)
مصطلحات موضوعية: Aged, Aminobutyrates/adverse effects/therapeutic use, Angiotensin Receptor Antagonists/adverse effects/therapeutic use, Angiotensin-Converting Enzyme Inhibitors/adverse effects/therapeutic use, Double-Blind Method, Drug Combinations, Enalapril/adverse effects/therapeutic use, Female, Heart Failure/drug therapy/mortality, Hospitalization/statistics & numerical data, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Neprilysin/antagonists & inhibitors, Stroke Volume, Tetrazoles/adverse effects/therapeutic use, Human health sciences, Cardiovascular & respiratory systems, Sciences de la santé humaine, Systèmes cardiovasculaire & respiratoire
العلاقة: urn:issn:0028-4793; urn:issn:1533-4406; https://orbilu.uni.lu/handle/10993/27659Test; info:hdl:10993/27659; https://orbilu.uni.lu/bitstream/10993/27659/1/nejmoa1409077.pdfTest; scopus-id:2-s2.0-84907087561; info:pmid:25176015; wos:000341382800005
الإتاحة: https://doi.org/10.1056/NEJMoa1409077Test
https://orbilu.uni.lu/handle/10993/27659Test
https://orbilu.uni.lu/bitstream/10993/27659/1/nejmoa1409077.pdfTest -
3دورية أكاديمية
المؤلفون: Puig, Juan Garcia, Marre, Michel, Kokot, Franciszek, Fernandez, Margarita, Jermendy, Gyorgy, Opie, Lionel, Moyseev, Valentin, Scheen, André, Ionescu-Tirgoviste, Constantin, Saldanha, M Helena, Halabe, Aaron, Williams, Bryan, Mion, Decio Jr, Ruiz, Maximino, Hermansen, Kjeld, Tuomilehto, Jaakko, Finizola, Bartolome, Gallois, Yves, Amouyel, Philippe, Ollivier, Jean-Pierre, Asmar, Roland
المصدر: American Journal of Hypertension, 20 (1), 90-7 (2007)
مصطلحات موضوعية: Aged, Albuminuria/drug therapy, Antihypertensive Agents/adverse effects/therapeutic use, Diabetes Mellitus, Type 2/complications, Enalapril/adverse effects/therapeutic use, Female, Humans, Hypertension/complications/drug therapy, Indapamide/adverse effects/therapeutic use, Kidney Function Tests, Male, Human health sciences, Cardiovascular & respiratory systems, Endocrinology, metabolism & nutrition, Sciences de la santé humaine, Systèmes cardiovasculaire & respiratoire, Endocrinologie, métabolisme & nutrition
العلاقة: http://www.nature.com/ajh/archive/index.htmlTest; urn:issn:0895-7061; urn:issn:1941-7225; https://orbi.uliege.be/handle/2268/8997Test; info:hdl:2268/8997; https://orbi.uliege.be/bitstream/2268/8997/1/Efficacy%20of%20Indapamide%20SR_ocr.pdfTest; scopus-id:2-s2.0-33845880883; info:pmid:17198918
الإتاحة: https://doi.org/10.1016/j.amjhyper.2006.05.018Test
https://orbi.uliege.be/handle/2268/8997Test
https://orbi.uliege.be/bitstream/2268/8997/1/Efficacy%20of%20Indapamide%20SR_ocr.pdfTest -
4دورية أكاديمية
المؤلفون: Mogensen, Carl Erik, Viberti, Giancarlo, Halimi, Serge, Ritz, Eberhard, Ruilope, Luis, Jermendy, Gyorgy, Widimsky, Jiri, Sareli, Pinchas, Taton, Jan, Rull, Juan, Erdogan, Gurbuz, De Leeuw, Pieter W, Ribeiro, Arthur, Sanchez, Ramiro, Mechmeche, Rachid, Nolan, John, Sirotiakova, Jana, Hamani, Ahmed, Scheen, André, Hess, Bernhard, Luger, Anton, Thomas, Stephen M
المصدر: Hypertension, 41 (5), 1063-71 (2003)
مصطلحات موضوعية: angiotensin-converting enzyme, diabetes mellitus, hypertension, renal, microalbuminuria, albuminuria, Adult, Aged, Albuminuria/drug therapy/etiology/urine, Antihypertensive Agents/adverse effects/therapeutic use, Blood Pressure/drug effects, Cough/chemically induced, Type 2/complications/physiopathology, Dizziness/chemically induced, Dose-Response Relationship, Drug, Double-Blind Method, Drug Therapy, Combination, Enalapril/adverse effects/therapeutic use, Female, Follow-Up Studies, Humans, Indapamide/adverse effects/therapeutic use, Male, Middle Aged, Perindopril/adverse effects/therapeutic use, Treatment Outcome, Human health sciences, Pharmacy
العلاقة: http://hyper.ahajournals.org/cgi/content/full/41/5/1063Test; urn:issn:0194-911X; urn:issn:1524-4563; https://orbi.uliege.be/handle/2268/2077Test; info:hdl:2268/2077; https://orbi.uliege.be/bitstream/2268/2077/1/Scheen_A_2003_hyp_1063.pdfTest; scopus-id:2-s2.0-0038185261; info:pmid:12654706
الإتاحة: https://doi.org/10.1161/01.HYP.0000064943.51878.58Test
https://orbi.uliege.be/handle/2268/2077Test
https://orbi.uliege.be/bitstream/2268/2077/1/Scheen_A_2003_hyp_1063.pdfTest -
5
المؤلفون: Aleksandr Svistov, YAN CARLOS DUARTE VERA, Lars Kober, Konstantin Ramshev, David Preiss, Miguel Urina, Sotir Marchev, Peter Olexa, Søren Lund Kristensen, Albert HAGEGE, Pardeep Jhund, Mamas Mamas, Ali Vazir, Michel GALINIER, Vladimir Rafalskiy, John Mcmurray, Angus Nightingale, Fernando Lanas, MICHELE SENNI, Jose Silva-Cardoso, Michael Zile, José Albuquerque De Figueiredo Neto, Elena Shutemova, Raj Mohindra, Natalie Bello, Gian Battista Danzi
المساهمون: Neyses, Ludwig [collaborator]
المصدر: Kristensen, S L, Preiss, D, Jhund, P S, Squire, I, Cardoso, J S, Merkely, B, Martinez, F, Starling, R C, Desai, A S, Lefkowitz, M P, Rizkala, A R, Rouleau, J L, Shi, V C, Solomon, S D, Swedberg, K, Zile, M R, McMurray, J J V, Packer, M & PARADIGM-HF Investigators and Committees 2016, ' Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction : Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial ', Circulation. Heart Failure, vol. 9, no. 1 . https://doi.org/10.1161/CIRCHEARTFAILURE.115.002560Test
Circulation. Heart Failure
Circulation. Heart failure, 9(1). United States (2016).مصطلحات موضوعية: Blood Glucose, Male, Prediabetic State/blood, Time Factors, endocrine system diseases, Heart Failure/blood/diagnosis/drug therapy/mortality/physiopathology, Left, heart failure, Tetrazoles, Aminobutyrates/adverse effects, Angiotensin-Converting Enzyme Inhibitors, Comorbidity, Kaplan-Meier Estimate, 030204 cardiovascular system & hematology, Sacubitril, Ventricular Function, Left, Multidisciplinaire, généralités & autres [F99] [Sciences du vivant], 0302 clinical medicine, Enalapril, Risk Factors, Diabetes Mellitus/blood, Prevalence, Heart Failure/blood, Ventricular Function, Single-Blind Method, 030212 general & internal medicine, Prospective Studies, Enalapril/adverse effects/therapeutic use, Prediabetic State/blood/diagnosis/epidemiology/mortality, Ejection fraction, Aminobutyrates, Hazard ratio, clinical trial, Hemoglobin A, Angiotensin Receptor Antagonists/adverse effects, Middle Aged, Clinical trial, Drug Combinations, Treatment Outcome, Valsartan, Angiotensin-Converting Enzyme Inhibitors/adverse effects, diabetes mellitus, Cardiology, Female, Tetrazoles/adverse effects, Cardiology and Cardiovascular Medicine, medicine.drug, medicine.medical_specialty, prognosis, treatment outcome, Aged, Angiotensin Receptor Antagonists, Biomarkers, Diabetes Mellitus, Disease-Free Survival, Heart Failure, Hemoglobin A, Glycosylated, Humans, Prediabetic State, Proportional Hazards Models, Risk Assessment, Stroke Volume, Glycated Hemoglobin A/metabolism, Glycosylated, Multidisciplinary, general & others [F99] [Life sciences], Diabetes Mellitus/blood/diagnosis/epidemiology/mortality, Enalapril/adverse effects, Hemoglobin A, Glycosylated/metabolism, 03 medical and health sciences, Angiotensin-Converting Enzyme Inhibitors/adverse effects/therapeutic use, Diabetes mellitus, Internal medicine, medicine, Glycated Hemoglobin, Blood Glucose/metabolism, business.industry, Proportional hazards model, Biphenyl Compounds, Angiotensin Receptor Antagonists/adverse effects/therapeutic use, nutritional and metabolic diseases, Aminobutyrates/adverse effects/therapeutic use, Original Articles, medicine.disease, Surgery, Tetrazoles/adverse effects/therapeutic use, Heart failure, business, Biomarkers/blood
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4175b6b03be4e6fe28284823591aa9dbTest
http://hdl.handle.net/11573/885449Test -
6
المؤلفون: Aleksandr Svistov, Oksana Drapkina, William Strain, YAN CARLOS DUARTE VERA, Lars Kober, Julio Núñez, Konstantin Ramshev, Manuel Martinez-Selles, Miguel Urina, Thomas Muenzel, Kamal Sharma, Sotir Marchev, MEHMET BIRHAN YILMAZ, Zbigniew Pijanowski, Peter Olexa, Albert HAGEGE, Pardeep Jhund, Mamas Mamas, Jan Krupicka, Marcelo Sanmartin-Fernandez, Michel GALINIER, Vladimir Rafalskiy, John Mcmurray, Roman Libis, Angus Nightingale, Fernando Lanas, MICHELE SENNI, Richard Bogle, Michael Zile, José Albuquerque De Figueiredo Neto, Biykem Bozkurt, Philippe Gosse, Evgeny Zhilyaev, Elena Shutemova, Fernando Manzur, Raj Mohindra, Natalie Bello, Gian Battista Danzi, DİLEK URAL, ROMAN FREIXA-PAMIAS
المساهمون: Neyses, Ludwig [collaborator]
المصدر: Dipòsit Digital de la UB
Universidad de Barcelona
The New England journal of medicine, 371(11), 993-1004. United States (2014).
McMurray, J J V, Packer, M, Desai, A S, Gong, J, Lefkowitz, M P, Rizkala, A R, Rouleau, J L, Shi, V C, Solomon, S D, Swedberg, K, Zile, M R & PARADIGM-HF Investigators and Committees 2014, ' Angiotensin-neprilysin inhibition versus enalapril in heart failure ', The New England Journal of Medicine, vol. 371, no. 11, pp. 993-1004 . https://doi.org/10.1056/NEJMoa1409077Testمصطلحات موضوعية: Male, Hyperkalemia, Tetrazoles, Angiotensin-Converting Enzyme Inhibitors, Aminobutyrates/adverse effects, Kaplan-Meier Estimate, Insuficiència cardíaca, Sacubitril, Enalapril, Ús terapèutic, Enalapril/adverse effects/therapeutic use, Ejection fraction, Aminobutyrates, Hazard ratio, General Medicine, Angiotensin Receptor Antagonists/adverse effects, Middle Aged, Systèmes cardiovasculaire & respiratoire [D03] [Sciences de la santé humaine], Hospitalization, Drug Combinations, Valsartan, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Cardiology, Neprilysin, Female, medicine.symptom, Tetrazoles/adverse effects, medicine.drug, Angiotensines, medicine.medical_specialty, Angiotensins, Heart failure, Enalapril/adverse effects, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors/adverse effects/therapeutic use, Double-Blind Method, Internal medicine, medicine, Humans, Aged, Hospitalization/statistics & numerical data, Heart Failure, business.industry, Heart Failure/drug therapy/mortality, Biphenyl Compounds, Angiotensin Receptor Antagonists/adverse effects/therapeutic use, Therapeutic use, Stroke Volume, Aminobutyrates/adverse effects/therapeutic use, medicine.disease, Heart Failure/drug therapy, R1, Endocrinology, Tetrazoles/adverse effects/therapeutic use, Cardiovascular & respiratory systems [D03] [Human health sciences], business, Neprilysin/antagonists & inhibitors, RA, Sacubitril, Valsartan
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::057eafc951e64542d7bae65b6ab4fe32Test
http://hdl.handle.net/2445/178508Test -
7مورد إلكتروني
مصطلحات الفهرس: Aged, Aminobutyrates/adverse effects/therapeutic use, Angiotensin Receptor Antagonists/adverse effects/therapeutic use, Angiotensin-Converting Enzyme Inhibitors/adverse effects/therapeutic use, Biomarkers/blood, Blood Glucose/metabolism, Comorbidity, Diabetes Mellitus/blood/diagnosis/epidemiology/mortality, Disease-Free Survival, Drug Combinations, Enalapril/adverse effects/therapeutic use, Female, Heart Failure/blood/diagnosis/drug therapy/mortality/physiopathology, Hemoglobin A, Glycosylated/metabolism, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Prediabetic State/blood/diagnosis/epidemiology/mortality, Prevalence, Proportional Hazards Models, Prospective Studies, Risk Assessment, Risk Factors, Single-Blind Method, Stroke Volume, Tetrazoles/adverse effects/therapeutic use, Time Factors, Treatment Outcome, Ventricular Function, Left, clinical trial, diabetes mellitus, heart failure, prognosis, treatment outcome, info:eu-repo/semantics/article
URL:
http://orbilu.uni.lu/handle/10993/29587Test http://orbilu.uni.lu/bitstream/10993/29587/1/hhf-9-e002560.pdfTest -
8مورد إلكتروني
مصطلحات الفهرس: Aged, Aminobutyrates/adverse effects/therapeutic use, Angiotensin Receptor Antagonists/adverse effects/therapeutic use, Angiotensin-Converting Enzyme Inhibitors/adverse effects/therapeutic use, Biomarkers/blood, Blood Glucose/metabolism, Comorbidity, Diabetes Mellitus/blood/diagnosis/epidemiology/mortality, Disease-Free Survival, Drug Combinations, Enalapril/adverse effects/therapeutic use, Female, Heart Failure/blood/diagnosis/drug therapy/mortality/physiopathology, Hemoglobin A, Glycosylated/metabolism, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Prediabetic State/blood/diagnosis/epidemiology/mortality, Prevalence, Proportional Hazards Models, Prospective Studies, Risk Assessment, Risk Factors, Single-Blind Method, Stroke Volume, Tetrazoles/adverse effects/therapeutic use, Time Factors, Treatment Outcome, Ventricular Function, Left, clinical trial, diabetes mellitus, heart failure, prognosis, treatment outcome, info:eu-repo/semantics/article
URL:
http://orbilu.uni.lu/handle/10993/29587Test http://orbilu.uni.lu/bitstream/10993/29587/1/hhf-9-e002560.pdfTest -
9مورد إلكتروني
مصطلحات الفهرس: Aged, Aminobutyrates/adverse effects/therapeutic use, Angiotensin Receptor Antagonists/adverse effects/therapeutic use, Angiotensin-Converting Enzyme Inhibitors/adverse effects/therapeutic use, Double-Blind Method, Drug Combinations, Enalapril/adverse effects/therapeutic use, Female, Heart Failure/drug therapy/mortality, Hospitalization/statistics & numerical data, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Neprilysin/antagonists & inhibitors, Stroke Volume, Tetrazoles/adverse effects/therapeutic use, info:eu-repo/semantics/article
-
10مورد إلكتروني
مصطلحات الفهرس: Aged, Aminobutyrates/adverse effects/therapeutic use, Angiotensin Receptor Antagonists/adverse effects/therapeutic use, Angiotensin-Converting Enzyme Inhibitors/adverse effects/therapeutic use, Double-Blind Method, Drug Combinations, Enalapril/adverse effects/therapeutic use, Female, Heart Failure/drug therapy/mortality, Hospitalization/statistics & numerical data, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Neprilysin/antagonists & inhibitors, Stroke Volume, Tetrazoles/adverse effects/therapeutic use, info:eu-repo/semantics/article